subject area of
- Clinical Course and Molecular Viral Shedding Among Asymptomatic and Symptomatic Patients With SARS-CoV-2 Infection in a Community Treatment Center in the Republic of Korea Academic Article
- Differential Responses of Murine Vaginal and Uterine Epithelial Cells Prior to and Following Herpes Simplex Virus Type 2 (HSV-2) Infection Academic Article
- In patients with COVID-19, viral shedding time is 17 d and varies in some subgroups Academic Article
- Longitudinal Study of Influenza Molecular Viral Shedding in Hutterite Communities Academic Article
- Maraba virus-vectored cancer vaccines represent a safe and novel therapeutic option for cats Academic Article
- Novel Role for Interleukin-17 in Enhancing Type 1 Helper T Cell Immunity in the Female Genital Tract following Mucosal Herpes Simplex Virus 2 Vaccination Academic Article
- Pandemic (H1N1) 2009 influenza in Canadian pediatric cancer and hematopoietic stem cell transplant patients Academic Article
- Peginterferon lambda for the treatment of outpatients with COVID-19: a phase 2, placebo-controlled randomised trial Academic Article
- Population-level effects of suppressing fever Academic Article
- Predictors of influenza a molecular viral shedding in Hutterite communities Academic Article
- Preliminary Assessment of the Efficacy of a T-Cell–Based Influenza Vaccine, MVA-NP+M1, in Humans Academic Article
- Prolonged Exposure to Progesterone Prevents Induction of Protective Mucosal Responses following Intravaginal Immunization with Attenuated Herpes Simplex Virus Type 2 Academic Article
- Prolonged shedding of rhinovirus and re-infection in adults with respiratory tract illness Academic Article